Cannabis as a medicinal agent has been used for thousands of years as an alternative remedy/therapy in many civilizations dating back to 10,000 BCE. 

Cannabis has recently come in light and evidence gathered in recent studies suggests that cannabis and its therapeutics/ medicinal properties can be used to cure or reduce pain associated with many illnesses and disorders; reducing symptoms associated with, but not limited to the following medical conditions:

1. Oncology (Cancers, Hep C etc.)
2. Chronic and Rheumatic Pain (Arthritis, Glaucoma etc.)
3. Gastro-Intestinal diseases and disorders (IBS, Crohn's and Ulcerative Colitis etc.)
4. Psychological (PTSD, Depression, Insomnia/Sleep Depravation etc.)
5. Neurological (Alzheimer's, MS etc.)
6. Physiological Disorders (Autism,Epileptic Seizures ect.)

Annual Cost of Pain: $630 billion+

According to our research, there are 1.5 billion people suffering from chronic pain around the globe, costing US $635 billion in days worked missed, hours of worked lost and lower wages; which is more than Diabetes, Cancer & Heart Diseases combined.  The Bio Pharmaceutical Cannabis Market is estimated to be over $190 billion dollars.

We are working towards developing web based platforms and other innovative solutions to serve our community of patients, protect our youths and help with creating socially responsible communities supported by our network of patients, health care professionals, collaborative partners, sponsors, governing entities and other stakeholders. 

These platforms will help shape the medicinal cannabis industry by:

1.  Enhancing patient care management processes to improve access to care for our patients.
2. Improving youth and community engagement through education and awareness.
3. Using big data from clinical studies and clinical trials as a driver of change in decision making, policy development and patient care.
4. Creating more opportunities for research, innovation and product development.
5. Creating new jobs, promoting Canadian values, ethics and showcasing Canadian businesses, entrepreneurs and subject matter experts to the world.
6. Encouraging dialogue and advocacy for patient’s rights, protection of our youths and safety of our communities.
7. Addressing the shortfalls and challenges in managing public perceptions, legislation, governance and oversight.

There are thousands of global studies being conducted currently:

1. To develop and implement policies, programs and frameworks needed.
2. To find efficacy of the cannabis as a safe and viable medicinal alternative in treating many illnesses.
3. To develop public education and community planning strategies while managing perceptions, expectations and concerns of the citizens.
4. To further research in to product and services development.
5. To develop business and market strategies for new products and services.
6. To assess impacts/benefits of recreational legalization.
7. To enforce and control illicit market, misuse and abuse.
8. To understand and project  market capacity and trends for economic growth and stimulation through job creation and new standards development.